To provide expertise and support from a variety of experts in the biomedical field in order to establish, strengthen, and further develop clinical and research laboratories throughout the world.
The Company is taking a three-pronged approach to its business development, targeting opportunities globally.
- First - provide services to existing clinical diagnostics laboratories to comply with all country and international regulatory standards
- Second - set up and run Company-owned compliant diagnostic laboratories using funding provided by private investors/major corporations.
- Third - create a direct pipeline for US drug and clinical diagnostic developers to access unique patient populations and clinical samples, and to manage clinical trials using those sources.